Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Monday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Down 6.5 %

Shares of RVP opened at $0.75 on Monday. The company has a market capitalization of $22.32 million, a P/E ratio of -1.38 and a beta of 1.94. Retractable Technologies has a one year low of $0.56 and a one year high of $1.34. The business’s 50 day simple moving average is $0.66 and its 200-day simple moving average is $0.86. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.